Tag: Patient Safety

Air, environmental sampling for COVID-19 around hospitalized patients

Editor's Note This study led by researchers from the department of microbiology, Queen Mary Hospital, Hong Kong, found that COVID-19 RNA [ribonucleic acid] was not detectable by air samplers, suggesting that the airborne route is not the predominant mode of transmission. The researchers sampled air close to six asymptomatic and…

Read More

By: Judy Mathias
October 29, 2020
Share

Association of stay-at-home orders and state-level rates of African American’s with COVID-19

Editor's Note A state’s stay-at-home orders (SAHOs) were associated with reductions in COVID-19 cases and fatality rates between March and May 2020, and a state’s number of African Americans was associated with more COVID-19 cases and fatalities in this study from the University of Alabama at Birmingham. Of 3,023 pooled…

Read More

By: Judy Mathias
October 29, 2020
Share

Study: Aspirin use linked to decreased COVID-19 mortality

Editor's Note In this study led by researchers from the University of Maryland School f Medicine, Baltimore, hospitalized COVID-19 patients who took low-dose aspirin daily for their heart health had a 47% lower risk of dying in the hospital than those who did not take aspirin. This retrospective analysis of…

Read More

By: Judy Mathias
October 28, 2020
Share

Joint Commission selected to provide VA lab accreditation

Editor's Note The Joint Commission announced October 27 that it had been selected to provide Laboratory Accreditation Program services for the US Department of Veterans Affairs (VA). These services will be provided for moderate and high-complexity clinical laboratories at VA Medical Centers and community-based outpatient clinics. Services include education on…

Read More

By: Judy Mathias
October 28, 2020
Share

CDC: COVID-19-associated hospitalizations of HCWs

Editor's Note In the October 26 Morbidity and Mortality Weekly Report, an analysis led by researchers from the Centers for Disease Control and Prevention (CDC) of hospitalization data from 13 states found that 5.9% of adults hospitalized with COVID-19 between March 1 and May 31 were healthcare workers (HCWs). Among…

Read More

By: Judy Mathias
October 27, 2020
Share

FDA drafting protocols to track COVID-19 vaccine safety

Editor's Note The Food and Drug Administration’s (FDA’s) Office of Biostatistics and Epidemiology is currently developing master protocols to be used in monitoring the safety and effectiveness of a COVID-19 vaccine once it is authorized or approved, in addition to postmarket surveillance requirements, the October 22 Regulatory Focus reports. The…

Read More

By: Judy Mathias
October 27, 2020
Share

COVID-19 in a correctional facility officer after multiple brief exposures to infected persons

Editor's Note In this study from the Vermont Departments of Health and Corrections and the Centers for Disease Control and Prevention (CDC), an officer at a correctional facility in Vermont was found to test positive for the COVID-19 virus on August 11 after multiple brief exposures to six infected incarcerated…

Read More

By: Judy Mathias
October 26, 2020
Share

CDC updates definition of ‘close contact’

Editor's Note The Centers for Disease Control and Prevention (CDC) on October 21 updated its COVID-19 “close contact” definition to being “within 6 feet of an infected person for a cumulative total of 15 minutes or more over a 24-hour period,” even if the time isn’t consecutive. The previous definition…

Read More

By: Judy Mathias
October 26, 2020
Share

Study finds routine COVID-19 screening of HCWs unnecessary

Editor's Note Researchers at Michigan State University College of Human Medicine and Mercy Health Saint Mary’s Hospital, Grand Rapids, Michigan, studied the COVID-19 positivity rate of asymptomatic healthcare workers (HCWs) in a 283-bed teaching hospital, and they to conclude that routine testing of HCWs is unnecessary. To effectively cohort patients,…

Read More

By: Judy Mathias
October 22, 2020
Share

ECRI warns of fast-tracking COVID-19 vaccines

Editor's Note ECRI announced October 21 that its President and CEO, Marcus Schabacker, MD, PhD, will tell the Food & Drug Administration Vaccines and Related Biological Products Advisory Committee on October 22 that a thorough review of 6 months of completed clinical trial data for COVID-19 vaccines is needed to…

Read More

By: Judy Mathias
October 22, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat